Compare AVXL & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVXL | JACK |
|---|---|---|
| Founded | 2004 | 1951 |
| Country | United States | United States |
| Employees | 34 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.1M | 178.8M |
| IPO Year | 2013 | 1994 |
| Metric | AVXL | JACK |
|---|---|---|
| Price | $3.24 | $11.72 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 14 |
| Target Price | ★ $22.00 | $21.93 |
| AVG Volume (30 Days) | ★ 2.0M | 969.6K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,465,314,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.61 | $8.92 |
| 52 Week High | $13.99 | $27.74 |
| Indicator | AVXL | JACK |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 45.83 |
| Support Level | $2.93 | $8.92 |
| Resistance Level | $4.88 | $20.96 |
| Average True Range (ATR) | 0.19 | 0.79 |
| MACD | 0.04 | 0.45 |
| Stochastic Oscillator | 87.02 | 81.24 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America. Its core business includes the Jack in the Box hamburger chain, known for a broad menu that features hamburgers, tacos, sandwiches, salads, and breakfast items. The company also operates the Del Taco brand, which offers a variety of both Mexican and American favorites such as burritos and fries. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.